Replacing art with numbers: decongesting congestive heart failure

摘要

This article refers to `Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society' by A.R. Lyon et al., published in this issue on pages xxx.